Global Pharyngitis Drug Production, Demand and Key Producers, 2022-2028
Pharyngitis is a clinical disorder that involves inflammation in the pharynx i.e. the back of the throat. A painful throat is referred to as pharyngitis. Itching and trouble swallowing are other symptoms of pharyngitis. Pharyngitis is caused by a variety of bacterial and viral agents, the most common of which are measles, adenovirus, high cough, and streptococcus. A viral infection, e.g. the common cold, influenza, or mononucleosis, is the most prevalent cause of pharyngitis.
This report studies the global Pharyngitis Drug production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Pharyngitis Drug, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Pharyngitis Drug that contribute to its increasing demand across many markets.
The global Pharyngitis Drug market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Pharyngitis Drug total production and demand, 2017-2028, (K Units)
Global Pharyngitis Drug total production value, 2017-2028, (USD Million)
Global Pharyngitis Drug production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Pharyngitis Drug consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: Pharyngitis Drug domestic production, consumption, key domestic manufacturers and share
Global Pharyngitis Drug production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global Pharyngitis Drug production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Pharyngitis Drug production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global Pharyngitis Drug market based on the following parameters – headquarters, production locations, products portfolio, Pharyngitis Drug revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Pharyngitis Drug market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Pharyngitis Drug Market, By Region:
1. How big is the global Pharyngitis Drug market?
2. What is the demand of the global Pharyngitis Drug market?
3. What is the year over year growth of the global Pharyngitis Drug market?
4. What is the production and production value of the global Pharyngitis Drug market?
5. Who are the key producers in the global Pharyngitis Drug market?
6. What are the growth factors driving the market demand?
This report studies the global Pharyngitis Drug production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Pharyngitis Drug, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Pharyngitis Drug that contribute to its increasing demand across many markets.
The global Pharyngitis Drug market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Pharyngitis Drug total production and demand, 2017-2028, (K Units)
Global Pharyngitis Drug total production value, 2017-2028, (USD Million)
Global Pharyngitis Drug production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Pharyngitis Drug consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: Pharyngitis Drug domestic production, consumption, key domestic manufacturers and share
Global Pharyngitis Drug production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global Pharyngitis Drug production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Pharyngitis Drug production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global Pharyngitis Drug market based on the following parameters – headquarters, production locations, products portfolio, Pharyngitis Drug revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Pharyngitis Drug market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Pharyngitis Drug Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Tablet
- Capsule
- Spray
- Solution
- Other
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Genentech Inc
- Adamas Pharmaceutical Inc
- PLIVA HRVATSKA d.o.o
- Pfizer Inc
- Valeant Pharmaceuticals International, Inc
- Mylan N.V
- GSK group of companies
- Teva Pharmaceutical Industries Ltd
- AbbVie Inc
- Viatris Inc. (Mylan)
- GlaxoSmithKline plc
- Abbott Laboratories
- Amgen Inc
- Sanofi-aventis Groupe
- Purdue Pharma L.P
1. How big is the global Pharyngitis Drug market?
2. What is the demand of the global Pharyngitis Drug market?
3. What is the year over year growth of the global Pharyngitis Drug market?
4. What is the production and production value of the global Pharyngitis Drug market?
5. Who are the key producers in the global Pharyngitis Drug market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Pharyngitis Drug Introduction
1.2 World Pharyngitis Drug Supply & Forecast
1.2.1 World Pharyngitis Drug Production Value (2017 & 2021 & 2028)
1.2.2 World Pharyngitis Drug Production (2017-2028)
1.2.3 World Pharyngitis Drug Pricing Trends (2017-2028)
1.3 World Pharyngitis Drug Production by Region
1.3.1 World Pharyngitis Drug Production Value by Region (2017-2028)
1.3.2 World Pharyngitis Drug Production by Region (2017-2028)
1.3.3 World Pharyngitis Drug Average Price by Region (2017-2028)
1.3.4 North America Pharyngitis Drug Production (2017-2028)
1.3.5 Europe Pharyngitis Drug Production (2017-2028)
1.3.6 China Pharyngitis Drug Production (2017-2028)
1.3.7 Japan Pharyngitis Drug Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Pharyngitis Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Pharyngitis Drug Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Pharyngitis Drug Demand (2017-2028)
2.2 World Pharyngitis Drug Consumption by Region
2.2.1 World Pharyngitis Drug Consumption by Region (2017-2022)
2.2.2 World Pharyngitis Drug Consumption Forecast by Region (2023-2028)
2.3 United States Pharyngitis Drug Consumption (2017-2028)
2.4 China Pharyngitis Drug Consumption (2017-2028)
2.5 Europe Pharyngitis Drug Consumption (2017-2028)
2.6 Japan Pharyngitis Drug Consumption (2017-2028)
2.7 South Korea Pharyngitis Drug Consumption (2017-2028)
2.8 ASEAN Pharyngitis Drug Consumption (2017-2028)
2.9 India Pharyngitis Drug Consumption (2017-2028)
3 WORLD PHARYNGITIS DRUG MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Pharyngitis Drug Production Value by Manufacturer (2017-2022)
3.2 World Pharyngitis Drug Production by Manufacturer (2017-2022)
3.3 World Pharyngitis Drug Average Price by Manufacturer (2017-2022)
3.4 Pharyngitis Drug Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Pharyngitis Drug Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Pharyngitis Drug in 2021
3.5.3 Global Concentration Ratios (CR8) for Pharyngitis Drug in 2021
3.6 Pharyngitis Drug Market: Overall Company Footprint Analysis
3.6.1 Pharyngitis Drug Market: Region Footprint
3.6.2 Pharyngitis Drug Market: Company Product Type Footprint
3.6.3 Pharyngitis Drug Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Pharyngitis Drug Production Value Comparison
4.1.1 United States VS China: Pharyngitis Drug Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Pharyngitis Drug Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Pharyngitis Drug Production Comparison
4.2.1 United States VS China: Pharyngitis Drug Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Pharyngitis Drug Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Pharyngitis Drug Consumption Comparison
4.3.1 United States VS China: Pharyngitis Drug Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Pharyngitis Drug Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Pharyngitis Drug Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Pharyngitis Drug in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Pharyngitis Drug Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Pharyngitis Drug Production by Domestic Manufacturer, (2017-2022)
4.5 China Pharyngitis Drug Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Pharyngitis Drug in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Pharyngitis Drug Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Pharyngitis Drug Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Pharyngitis Drug Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Pharyngitis Drug in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Pharyngitis Drug Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Pharyngitis Drug Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Pharyngitis Drug Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Tablet
5.2.2 Capsule
5.2.3 Spray
5.2.4 Solution
5.2.5 Other
5.3 Market Segment by Type
5.3.1 World Pharyngitis Drug Production by Type (2017-2028)
5.3.2 World Pharyngitis Drug Production Value by Type (2017-2028)
5.3.3 World Pharyngitis Drug Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Pharyngitis Drug Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Hospital Pharmacies
6.2.2 Retail Pharmacies
6.2.3 Online Pharmacies
6.3 Market Segment by Application
6.3.1 World Pharyngitis Drug Production by Application (2017-2028)
6.3.2 World Pharyngitis Drug Production Value by Application (2017-2028)
6.3.3 World Pharyngitis Drug Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 Genentech Inc
7.1.1 Genentech Inc Details
7.1.2 Genentech Inc Major Business
7.1.3 Genentech Inc Pharyngitis Drug Product and Services
7.1.4 Genentech Inc Pharyngitis Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 Genentech Inc Recent Developments/Updates
7.1.6 Genentech Inc Competitive Strengths & Weaknesses
7.2 Adamas Pharmaceutical Inc
7.2.1 Adamas Pharmaceutical Inc Details
7.2.2 Adamas Pharmaceutical Inc Major Business
7.2.3 Adamas Pharmaceutical Inc Pharyngitis Drug Product and Services
7.2.4 Adamas Pharmaceutical Inc Pharyngitis Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 Adamas Pharmaceutical Inc Recent Developments/Updates
7.2.6 Adamas Pharmaceutical Inc Competitive Strengths & Weaknesses
7.3 PLIVA HRVATSKA d.o.o
7.3.1 PLIVA HRVATSKA d.o.o Details
7.3.2 PLIVA HRVATSKA d.o.o Major Business
7.3.3 PLIVA HRVATSKA d.o.o Pharyngitis Drug Product and Services
7.3.4 PLIVA HRVATSKA d.o.o Pharyngitis Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 PLIVA HRVATSKA d.o.o Recent Developments/Updates
7.3.6 PLIVA HRVATSKA d.o.o Competitive Strengths & Weaknesses
7.4 Pfizer Inc
7.4.1 Pfizer Inc Details
7.4.2 Pfizer Inc Major Business
7.4.3 Pfizer Inc Pharyngitis Drug Product and Services
7.4.4 Pfizer Inc Pharyngitis Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Pfizer Inc Recent Developments/Updates
7.4.6 Pfizer Inc Competitive Strengths & Weaknesses
7.5 Valeant Pharmaceuticals International, Inc
7.5.1 Valeant Pharmaceuticals International, Inc Details
7.5.2 Valeant Pharmaceuticals International, Inc Major Business
7.5.3 Valeant Pharmaceuticals International, Inc Pharyngitis Drug Product and Services
7.5.4 Valeant Pharmaceuticals International, Inc Pharyngitis Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 Valeant Pharmaceuticals International, Inc Recent Developments/Updates
7.5.6 Valeant Pharmaceuticals International, Inc Competitive Strengths & Weaknesses
7.6 Mylan N.V
7.6.1 Mylan N.V Details
7.6.2 Mylan N.V Major Business
7.6.3 Mylan N.V Pharyngitis Drug Product and Services
7.6.4 Mylan N.V Pharyngitis Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Mylan N.V Recent Developments/Updates
7.6.6 Mylan N.V Competitive Strengths & Weaknesses
7.7 GSK group of companies
7.7.1 GSK group of companies Details
7.7.2 GSK group of companies Major Business
7.7.3 GSK group of companies Pharyngitis Drug Product and Services
7.7.4 GSK group of companies Pharyngitis Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 GSK group of companies Recent Developments/Updates
7.7.6 GSK group of companies Competitive Strengths & Weaknesses
7.8 Teva Pharmaceutical Industries Ltd
7.8.1 Teva Pharmaceutical Industries Ltd Details
7.8.2 Teva Pharmaceutical Industries Ltd Major Business
7.8.3 Teva Pharmaceutical Industries Ltd Pharyngitis Drug Product and Services
7.8.4 Teva Pharmaceutical Industries Ltd Pharyngitis Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
7.8.6 Teva Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
7.9 AbbVie Inc
7.9.1 AbbVie Inc Details
7.9.2 AbbVie Inc Major Business
7.9.3 AbbVie Inc Pharyngitis Drug Product and Services
7.9.4 AbbVie Inc Pharyngitis Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 AbbVie Inc Recent Developments/Updates
7.9.6 AbbVie Inc Competitive Strengths & Weaknesses
7.10 Viatris Inc. (Mylan)
7.10.1 Viatris Inc. (Mylan) Details
7.10.2 Viatris Inc. (Mylan) Major Business
7.10.3 Viatris Inc. (Mylan) Pharyngitis Drug Product and Services
7.10.4 Viatris Inc. (Mylan) Pharyngitis Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 Viatris Inc. (Mylan) Recent Developments/Updates
7.10.6 Viatris Inc. (Mylan) Competitive Strengths & Weaknesses
7.11 GlaxoSmithKline plc
7.11.1 GlaxoSmithKline plc Details
7.11.2 GlaxoSmithKline plc Major Business
7.11.3 GlaxoSmithKline plc Pharyngitis Drug Product and Services
7.11.4 GlaxoSmithKline plc Pharyngitis Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 GlaxoSmithKline plc Recent Developments/Updates
7.11.6 GlaxoSmithKline plc Competitive Strengths & Weaknesses
7.12 Abbott Laboratories
7.12.1 Abbott Laboratories Details
7.12.2 Abbott Laboratories Major Business
7.12.3 Abbott Laboratories Pharyngitis Drug Product and Services
7.12.4 Abbott Laboratories Pharyngitis Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 Abbott Laboratories Recent Developments/Updates
7.12.6 Abbott Laboratories Competitive Strengths & Weaknesses
7.13 Amgen Inc
7.13.1 Amgen Inc Details
7.13.2 Amgen Inc Major Business
7.13.3 Amgen Inc Pharyngitis Drug Product and Services
7.13.4 Amgen Inc Pharyngitis Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.13.5 Amgen Inc Recent Developments/Updates
7.13.6 Amgen Inc Competitive Strengths & Weaknesses
7.14 Sanofi-aventis Groupe
7.14.1 Sanofi-aventis Groupe Details
7.14.2 Sanofi-aventis Groupe Major Business
7.14.3 Sanofi-aventis Groupe Pharyngitis Drug Product and Services
7.14.4 Sanofi-aventis Groupe Pharyngitis Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.14.5 Sanofi-aventis Groupe Recent Developments/Updates
7.14.6 Sanofi-aventis Groupe Competitive Strengths & Weaknesses
7.15 Purdue Pharma L.P
7.15.1 Purdue Pharma L.P Details
7.15.2 Purdue Pharma L.P Major Business
7.15.3 Purdue Pharma L.P Pharyngitis Drug Product and Services
7.15.4 Purdue Pharma L.P Pharyngitis Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.15.5 Purdue Pharma L.P Recent Developments/Updates
7.15.6 Purdue Pharma L.P Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Pharyngitis Drug and Key Manufacturers
8.2 Pharyngitis Drug Manufacturing Costs
8.3 Pharyngitis Drug Production Process
8.4 Pharyngitis Drug Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Pharyngitis Drug Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Pharyngitis Drug Typical Distributors
9.3 Pharyngitis Drug Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
1.1 Pharyngitis Drug Introduction
1.2 World Pharyngitis Drug Supply & Forecast
1.2.1 World Pharyngitis Drug Production Value (2017 & 2021 & 2028)
1.2.2 World Pharyngitis Drug Production (2017-2028)
1.2.3 World Pharyngitis Drug Pricing Trends (2017-2028)
1.3 World Pharyngitis Drug Production by Region
1.3.1 World Pharyngitis Drug Production Value by Region (2017-2028)
1.3.2 World Pharyngitis Drug Production by Region (2017-2028)
1.3.3 World Pharyngitis Drug Average Price by Region (2017-2028)
1.3.4 North America Pharyngitis Drug Production (2017-2028)
1.3.5 Europe Pharyngitis Drug Production (2017-2028)
1.3.6 China Pharyngitis Drug Production (2017-2028)
1.3.7 Japan Pharyngitis Drug Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Pharyngitis Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Pharyngitis Drug Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Pharyngitis Drug Demand (2017-2028)
2.2 World Pharyngitis Drug Consumption by Region
2.2.1 World Pharyngitis Drug Consumption by Region (2017-2022)
2.2.2 World Pharyngitis Drug Consumption Forecast by Region (2023-2028)
2.3 United States Pharyngitis Drug Consumption (2017-2028)
2.4 China Pharyngitis Drug Consumption (2017-2028)
2.5 Europe Pharyngitis Drug Consumption (2017-2028)
2.6 Japan Pharyngitis Drug Consumption (2017-2028)
2.7 South Korea Pharyngitis Drug Consumption (2017-2028)
2.8 ASEAN Pharyngitis Drug Consumption (2017-2028)
2.9 India Pharyngitis Drug Consumption (2017-2028)
3 WORLD PHARYNGITIS DRUG MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Pharyngitis Drug Production Value by Manufacturer (2017-2022)
3.2 World Pharyngitis Drug Production by Manufacturer (2017-2022)
3.3 World Pharyngitis Drug Average Price by Manufacturer (2017-2022)
3.4 Pharyngitis Drug Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Pharyngitis Drug Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Pharyngitis Drug in 2021
3.5.3 Global Concentration Ratios (CR8) for Pharyngitis Drug in 2021
3.6 Pharyngitis Drug Market: Overall Company Footprint Analysis
3.6.1 Pharyngitis Drug Market: Region Footprint
3.6.2 Pharyngitis Drug Market: Company Product Type Footprint
3.6.3 Pharyngitis Drug Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Pharyngitis Drug Production Value Comparison
4.1.1 United States VS China: Pharyngitis Drug Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Pharyngitis Drug Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Pharyngitis Drug Production Comparison
4.2.1 United States VS China: Pharyngitis Drug Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Pharyngitis Drug Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Pharyngitis Drug Consumption Comparison
4.3.1 United States VS China: Pharyngitis Drug Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Pharyngitis Drug Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Pharyngitis Drug Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Pharyngitis Drug in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Pharyngitis Drug Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Pharyngitis Drug Production by Domestic Manufacturer, (2017-2022)
4.5 China Pharyngitis Drug Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Pharyngitis Drug in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Pharyngitis Drug Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Pharyngitis Drug Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Pharyngitis Drug Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Pharyngitis Drug in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Pharyngitis Drug Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Pharyngitis Drug Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Pharyngitis Drug Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Tablet
5.2.2 Capsule
5.2.3 Spray
5.2.4 Solution
5.2.5 Other
5.3 Market Segment by Type
5.3.1 World Pharyngitis Drug Production by Type (2017-2028)
5.3.2 World Pharyngitis Drug Production Value by Type (2017-2028)
5.3.3 World Pharyngitis Drug Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Pharyngitis Drug Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Hospital Pharmacies
6.2.2 Retail Pharmacies
6.2.3 Online Pharmacies
6.3 Market Segment by Application
6.3.1 World Pharyngitis Drug Production by Application (2017-2028)
6.3.2 World Pharyngitis Drug Production Value by Application (2017-2028)
6.3.3 World Pharyngitis Drug Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 Genentech Inc
7.1.1 Genentech Inc Details
7.1.2 Genentech Inc Major Business
7.1.3 Genentech Inc Pharyngitis Drug Product and Services
7.1.4 Genentech Inc Pharyngitis Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 Genentech Inc Recent Developments/Updates
7.1.6 Genentech Inc Competitive Strengths & Weaknesses
7.2 Adamas Pharmaceutical Inc
7.2.1 Adamas Pharmaceutical Inc Details
7.2.2 Adamas Pharmaceutical Inc Major Business
7.2.3 Adamas Pharmaceutical Inc Pharyngitis Drug Product and Services
7.2.4 Adamas Pharmaceutical Inc Pharyngitis Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 Adamas Pharmaceutical Inc Recent Developments/Updates
7.2.6 Adamas Pharmaceutical Inc Competitive Strengths & Weaknesses
7.3 PLIVA HRVATSKA d.o.o
7.3.1 PLIVA HRVATSKA d.o.o Details
7.3.2 PLIVA HRVATSKA d.o.o Major Business
7.3.3 PLIVA HRVATSKA d.o.o Pharyngitis Drug Product and Services
7.3.4 PLIVA HRVATSKA d.o.o Pharyngitis Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 PLIVA HRVATSKA d.o.o Recent Developments/Updates
7.3.6 PLIVA HRVATSKA d.o.o Competitive Strengths & Weaknesses
7.4 Pfizer Inc
7.4.1 Pfizer Inc Details
7.4.2 Pfizer Inc Major Business
7.4.3 Pfizer Inc Pharyngitis Drug Product and Services
7.4.4 Pfizer Inc Pharyngitis Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Pfizer Inc Recent Developments/Updates
7.4.6 Pfizer Inc Competitive Strengths & Weaknesses
7.5 Valeant Pharmaceuticals International, Inc
7.5.1 Valeant Pharmaceuticals International, Inc Details
7.5.2 Valeant Pharmaceuticals International, Inc Major Business
7.5.3 Valeant Pharmaceuticals International, Inc Pharyngitis Drug Product and Services
7.5.4 Valeant Pharmaceuticals International, Inc Pharyngitis Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 Valeant Pharmaceuticals International, Inc Recent Developments/Updates
7.5.6 Valeant Pharmaceuticals International, Inc Competitive Strengths & Weaknesses
7.6 Mylan N.V
7.6.1 Mylan N.V Details
7.6.2 Mylan N.V Major Business
7.6.3 Mylan N.V Pharyngitis Drug Product and Services
7.6.4 Mylan N.V Pharyngitis Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Mylan N.V Recent Developments/Updates
7.6.6 Mylan N.V Competitive Strengths & Weaknesses
7.7 GSK group of companies
7.7.1 GSK group of companies Details
7.7.2 GSK group of companies Major Business
7.7.3 GSK group of companies Pharyngitis Drug Product and Services
7.7.4 GSK group of companies Pharyngitis Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 GSK group of companies Recent Developments/Updates
7.7.6 GSK group of companies Competitive Strengths & Weaknesses
7.8 Teva Pharmaceutical Industries Ltd
7.8.1 Teva Pharmaceutical Industries Ltd Details
7.8.2 Teva Pharmaceutical Industries Ltd Major Business
7.8.3 Teva Pharmaceutical Industries Ltd Pharyngitis Drug Product and Services
7.8.4 Teva Pharmaceutical Industries Ltd Pharyngitis Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
7.8.6 Teva Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
7.9 AbbVie Inc
7.9.1 AbbVie Inc Details
7.9.2 AbbVie Inc Major Business
7.9.3 AbbVie Inc Pharyngitis Drug Product and Services
7.9.4 AbbVie Inc Pharyngitis Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 AbbVie Inc Recent Developments/Updates
7.9.6 AbbVie Inc Competitive Strengths & Weaknesses
7.10 Viatris Inc. (Mylan)
7.10.1 Viatris Inc. (Mylan) Details
7.10.2 Viatris Inc. (Mylan) Major Business
7.10.3 Viatris Inc. (Mylan) Pharyngitis Drug Product and Services
7.10.4 Viatris Inc. (Mylan) Pharyngitis Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 Viatris Inc. (Mylan) Recent Developments/Updates
7.10.6 Viatris Inc. (Mylan) Competitive Strengths & Weaknesses
7.11 GlaxoSmithKline plc
7.11.1 GlaxoSmithKline plc Details
7.11.2 GlaxoSmithKline plc Major Business
7.11.3 GlaxoSmithKline plc Pharyngitis Drug Product and Services
7.11.4 GlaxoSmithKline plc Pharyngitis Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 GlaxoSmithKline plc Recent Developments/Updates
7.11.6 GlaxoSmithKline plc Competitive Strengths & Weaknesses
7.12 Abbott Laboratories
7.12.1 Abbott Laboratories Details
7.12.2 Abbott Laboratories Major Business
7.12.3 Abbott Laboratories Pharyngitis Drug Product and Services
7.12.4 Abbott Laboratories Pharyngitis Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 Abbott Laboratories Recent Developments/Updates
7.12.6 Abbott Laboratories Competitive Strengths & Weaknesses
7.13 Amgen Inc
7.13.1 Amgen Inc Details
7.13.2 Amgen Inc Major Business
7.13.3 Amgen Inc Pharyngitis Drug Product and Services
7.13.4 Amgen Inc Pharyngitis Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.13.5 Amgen Inc Recent Developments/Updates
7.13.6 Amgen Inc Competitive Strengths & Weaknesses
7.14 Sanofi-aventis Groupe
7.14.1 Sanofi-aventis Groupe Details
7.14.2 Sanofi-aventis Groupe Major Business
7.14.3 Sanofi-aventis Groupe Pharyngitis Drug Product and Services
7.14.4 Sanofi-aventis Groupe Pharyngitis Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.14.5 Sanofi-aventis Groupe Recent Developments/Updates
7.14.6 Sanofi-aventis Groupe Competitive Strengths & Weaknesses
7.15 Purdue Pharma L.P
7.15.1 Purdue Pharma L.P Details
7.15.2 Purdue Pharma L.P Major Business
7.15.3 Purdue Pharma L.P Pharyngitis Drug Product and Services
7.15.4 Purdue Pharma L.P Pharyngitis Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.15.5 Purdue Pharma L.P Recent Developments/Updates
7.15.6 Purdue Pharma L.P Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Pharyngitis Drug and Key Manufacturers
8.2 Pharyngitis Drug Manufacturing Costs
8.3 Pharyngitis Drug Production Process
8.4 Pharyngitis Drug Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Pharyngitis Drug Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Pharyngitis Drug Typical Distributors
9.3 Pharyngitis Drug Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
LIST OF TABLES
Table 1. World Pharyngitis Drug Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Pharyngitis Drug Production Value by Region (2017-2022) & (USD Million)
Table 3. World Pharyngitis Drug Production Value by Region (2023-2028) & (USD Million)
Table 4. World Pharyngitis Drug Production Value Market Share by Region (2017-2022)
Table 5. World Pharyngitis Drug Production Value Market Share by Region (2023-2028)
Table 6. World Pharyngitis Drug Production by Region (2017-2022) & (K Units)
Table 7. World Pharyngitis Drug Production by Region (2023-2028) & (K Units)
Table 8. World Pharyngitis Drug Production Market Share by Region (2017-2022)
Table 9. World Pharyngitis Drug Production Market Share by Region (2023-2028)
Table 10. World Pharyngitis Drug Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Pharyngitis Drug Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Pharyngitis Drug Major Market Trends
Table 13. World Pharyngitis Drug Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Pharyngitis Drug Consumption by Region (2017-2022) & (K Units)
Table 15. World Pharyngitis Drug Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Pharyngitis Drug Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Pharyngitis Drug Producers in 2021
Table 18. World Pharyngitis Drug Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Pharyngitis Drug Producers in 2021
Table 20. World Pharyngitis Drug Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Pharyngitis Drug Company Evaluation Quadrant
Table 22. World Pharyngitis Drug Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Pharyngitis Drug Production Site of Key Manufacturer
Table 24. Pharyngitis Drug Market: Company Product Type Footprint
Table 25. Pharyngitis Drug Market: Company Product Application Footprint
Table 26. Pharyngitis Drug Competitive Factors
Table 27. Pharyngitis Drug New Entrant and Capacity Expansion Plans
Table 28. Pharyngitis Drug Mergers & Acquisitions Activity
Table 29. United States VS China Pharyngitis Drug Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Pharyngitis Drug Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Pharyngitis Drug Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Pharyngitis Drug in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Pharyngitis Drug Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Pharyngitis Drug Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Pharyngitis Drug Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Pharyngitis Drug Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Pharyngitis Drug in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Pharyngitis Drug Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Pharyngitis Drug Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Pharyngitis Drug Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Pharyngitis Drug Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Pharyngitis Drug in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Pharyngitis Drug Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Pharyngitis Drug Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Pharyngitis Drug Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Pharyngitis Drug Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Pharyngitis Drug Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Pharyngitis Drug Production by Type (2017-2022) & (K Units)
Table 49. World Pharyngitis Drug Production by Type (2023-2028) & (K Units)
Table 50. World Pharyngitis Drug Production Value by Type (2017-2022) & (USD Million)
Table 51. World Pharyngitis Drug Production Value by Type (2023-2028) & (USD Million)
Table 52. World Pharyngitis Drug Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Pharyngitis Drug Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Pharyngitis Drug Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Pharyngitis Drug Production by Application (2017-2022) & (K Units)
Table 56. World Pharyngitis Drug Production by Application (2023-2028) & (K Units)
Table 57. World Pharyngitis Drug Production Value by Application (2017-2022) & (USD Million)
Table 58. World Pharyngitis Drug Production Value by Application (2023-2028) & (USD Million)
Table 59. World Pharyngitis Drug Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Pharyngitis Drug Average Price by Application (2023-2028) & (US$/Unit)
Table 61. Genentech Inc Basic Information, Manufacturing Base and Competitors
Table 62. Genentech Inc Major Business
Table 63. Genentech Inc Pharyngitis Drug Product and Services
Table 64. Genentech Inc Pharyngitis Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Genentech Inc Recent Developments/Updates
Table 66. Genentech Inc Competitive Strengths & Weaknesses
Table 67. Adamas Pharmaceutical Inc Basic Information, Manufacturing Base and Competitors
Table 68. Adamas Pharmaceutical Inc Major Business
Table 69. Adamas Pharmaceutical Inc Pharyngitis Drug Product and Services
Table 70. Adamas Pharmaceutical Inc Pharyngitis Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. Adamas Pharmaceutical Inc Recent Developments/Updates
Table 72. Adamas Pharmaceutical Inc Competitive Strengths & Weaknesses
Table 73. PLIVA HRVATSKA d.o.o Basic Information, Manufacturing Base and Competitors
Table 74. PLIVA HRVATSKA d.o.o Major Business
Table 75. PLIVA HRVATSKA d.o.o Pharyngitis Drug Product and Services
Table 76. PLIVA HRVATSKA d.o.o Pharyngitis Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. PLIVA HRVATSKA d.o.o Recent Developments/Updates
Table 78. PLIVA HRVATSKA d.o.o Competitive Strengths & Weaknesses
Table 79. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 80. Pfizer Inc Major Business
Table 81. Pfizer Inc Pharyngitis Drug Product and Services
Table 82. Pfizer Inc Pharyngitis Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Pfizer Inc Recent Developments/Updates
Table 84. Pfizer Inc Competitive Strengths & Weaknesses
Table 85. Valeant Pharmaceuticals International, Inc Basic Information, Manufacturing Base and Competitors
Table 86. Valeant Pharmaceuticals International, Inc Major Business
Table 87. Valeant Pharmaceuticals International, Inc Pharyngitis Drug Product and Services
Table 88. Valeant Pharmaceuticals International, Inc Pharyngitis Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Valeant Pharmaceuticals International, Inc Recent Developments/Updates
Table 90. Valeant Pharmaceuticals International, Inc Competitive Strengths & Weaknesses
Table 91. Mylan N.V Basic Information, Manufacturing Base and Competitors
Table 92. Mylan N.V Major Business
Table 93. Mylan N.V Pharyngitis Drug Product and Services
Table 94. Mylan N.V Pharyngitis Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Mylan N.V Recent Developments/Updates
Table 96. Mylan N.V Competitive Strengths & Weaknesses
Table 97. GSK group of companies Basic Information, Manufacturing Base and Competitors
Table 98. GSK group of companies Major Business
Table 99. GSK group of companies Pharyngitis Drug Product and Services
Table 100. GSK group of companies Pharyngitis Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. GSK group of companies Recent Developments/Updates
Table 102. GSK group of companies Competitive Strengths & Weaknesses
Table 103. Teva Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 104. Teva Pharmaceutical Industries Ltd Major Business
Table 105. Teva Pharmaceutical Industries Ltd Pharyngitis Drug Product and Services
Table 106. Teva Pharmaceutical Industries Ltd Pharyngitis Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 108. Teva Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
Table 109. AbbVie Inc Basic Information, Manufacturing Base and Competitors
Table 110. AbbVie Inc Major Business
Table 111. AbbVie Inc Pharyngitis Drug Product and Services
Table 112. AbbVie Inc Pharyngitis Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. AbbVie Inc Recent Developments/Updates
Table 114. AbbVie Inc Competitive Strengths & Weaknesses
Table 115. Viatris Inc. (Mylan) Basic Information, Manufacturing Base and Competitors
Table 116. Viatris Inc. (Mylan) Major Business
Table 117. Viatris Inc. (Mylan) Pharyngitis Drug Product and Services
Table 118. Viatris Inc. (Mylan) Pharyngitis Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. Viatris Inc. (Mylan) Recent Developments/Updates
Table 120. Viatris Inc. (Mylan) Competitive Strengths & Weaknesses
Table 121. GlaxoSmithKline plc Basic Information, Manufacturing Base and Competitors
Table 122. GlaxoSmithKline plc Major Business
Table 123. GlaxoSmithKline plc Pharyngitis Drug Product and Services
Table 124. GlaxoSmithKline plc Pharyngitis Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. GlaxoSmithKline plc Recent Developments/Updates
Table 126. GlaxoSmithKline plc Competitive Strengths & Weaknesses
Table 127. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 128. Abbott Laboratories Major Business
Table 129. Abbott Laboratories Pharyngitis Drug Product and Services
Table 130. Abbott Laboratories Pharyngitis Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 131. Abbott Laboratories Recent Developments/Updates
Table 132. Abbott Laboratories Competitive Strengths & Weaknesses
Table 133. Amgen Inc Basic Information, Manufacturing Base and Competitors
Table 134. Amgen Inc Major Business
Table 135. Amgen Inc Pharyngitis Drug Product and Services
Table 136. Amgen Inc Pharyngitis Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 137. Amgen Inc Recent Developments/Updates
Table 138. Amgen Inc Competitive Strengths & Weaknesses
Table 139. Sanofi-aventis Groupe Basic Information, Manufacturing Base and Competitors
Table 140. Sanofi-aventis Groupe Major Business
Table 141. Sanofi-aventis Groupe Pharyngitis Drug Product and Services
Table 142. Sanofi-aventis Groupe Pharyngitis Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 143. Sanofi-aventis Groupe Recent Developments/Updates
Table 144. Purdue Pharma L.P Basic Information, Manufacturing Base and Competitors
Table 145. Purdue Pharma L.P Major Business
Table 146. Purdue Pharma L.P Pharyngitis Drug Product and Services
Table 147. Purdue Pharma L.P Pharyngitis Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 148. Pharyngitis Drug Raw Material
Table 149. Key Manufacturers of Pharyngitis Drug Raw Materials
Table 150. Pharyngitis Drug Typical Distributors
Table 151. Pharyngitis Drug Typical Customers
Table 1. World Pharyngitis Drug Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Pharyngitis Drug Production Value by Region (2017-2022) & (USD Million)
Table 3. World Pharyngitis Drug Production Value by Region (2023-2028) & (USD Million)
Table 4. World Pharyngitis Drug Production Value Market Share by Region (2017-2022)
Table 5. World Pharyngitis Drug Production Value Market Share by Region (2023-2028)
Table 6. World Pharyngitis Drug Production by Region (2017-2022) & (K Units)
Table 7. World Pharyngitis Drug Production by Region (2023-2028) & (K Units)
Table 8. World Pharyngitis Drug Production Market Share by Region (2017-2022)
Table 9. World Pharyngitis Drug Production Market Share by Region (2023-2028)
Table 10. World Pharyngitis Drug Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Pharyngitis Drug Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Pharyngitis Drug Major Market Trends
Table 13. World Pharyngitis Drug Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Pharyngitis Drug Consumption by Region (2017-2022) & (K Units)
Table 15. World Pharyngitis Drug Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Pharyngitis Drug Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Pharyngitis Drug Producers in 2021
Table 18. World Pharyngitis Drug Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Pharyngitis Drug Producers in 2021
Table 20. World Pharyngitis Drug Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Pharyngitis Drug Company Evaluation Quadrant
Table 22. World Pharyngitis Drug Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Pharyngitis Drug Production Site of Key Manufacturer
Table 24. Pharyngitis Drug Market: Company Product Type Footprint
Table 25. Pharyngitis Drug Market: Company Product Application Footprint
Table 26. Pharyngitis Drug Competitive Factors
Table 27. Pharyngitis Drug New Entrant and Capacity Expansion Plans
Table 28. Pharyngitis Drug Mergers & Acquisitions Activity
Table 29. United States VS China Pharyngitis Drug Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Pharyngitis Drug Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Pharyngitis Drug Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Pharyngitis Drug in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Pharyngitis Drug Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Pharyngitis Drug Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Pharyngitis Drug Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Pharyngitis Drug Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Pharyngitis Drug in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Pharyngitis Drug Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Pharyngitis Drug Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Pharyngitis Drug Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Pharyngitis Drug Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Pharyngitis Drug in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Pharyngitis Drug Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Pharyngitis Drug Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Pharyngitis Drug Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Pharyngitis Drug Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Pharyngitis Drug Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Pharyngitis Drug Production by Type (2017-2022) & (K Units)
Table 49. World Pharyngitis Drug Production by Type (2023-2028) & (K Units)
Table 50. World Pharyngitis Drug Production Value by Type (2017-2022) & (USD Million)
Table 51. World Pharyngitis Drug Production Value by Type (2023-2028) & (USD Million)
Table 52. World Pharyngitis Drug Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Pharyngitis Drug Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Pharyngitis Drug Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Pharyngitis Drug Production by Application (2017-2022) & (K Units)
Table 56. World Pharyngitis Drug Production by Application (2023-2028) & (K Units)
Table 57. World Pharyngitis Drug Production Value by Application (2017-2022) & (USD Million)
Table 58. World Pharyngitis Drug Production Value by Application (2023-2028) & (USD Million)
Table 59. World Pharyngitis Drug Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Pharyngitis Drug Average Price by Application (2023-2028) & (US$/Unit)
Table 61. Genentech Inc Basic Information, Manufacturing Base and Competitors
Table 62. Genentech Inc Major Business
Table 63. Genentech Inc Pharyngitis Drug Product and Services
Table 64. Genentech Inc Pharyngitis Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Genentech Inc Recent Developments/Updates
Table 66. Genentech Inc Competitive Strengths & Weaknesses
Table 67. Adamas Pharmaceutical Inc Basic Information, Manufacturing Base and Competitors
Table 68. Adamas Pharmaceutical Inc Major Business
Table 69. Adamas Pharmaceutical Inc Pharyngitis Drug Product and Services
Table 70. Adamas Pharmaceutical Inc Pharyngitis Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. Adamas Pharmaceutical Inc Recent Developments/Updates
Table 72. Adamas Pharmaceutical Inc Competitive Strengths & Weaknesses
Table 73. PLIVA HRVATSKA d.o.o Basic Information, Manufacturing Base and Competitors
Table 74. PLIVA HRVATSKA d.o.o Major Business
Table 75. PLIVA HRVATSKA d.o.o Pharyngitis Drug Product and Services
Table 76. PLIVA HRVATSKA d.o.o Pharyngitis Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. PLIVA HRVATSKA d.o.o Recent Developments/Updates
Table 78. PLIVA HRVATSKA d.o.o Competitive Strengths & Weaknesses
Table 79. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 80. Pfizer Inc Major Business
Table 81. Pfizer Inc Pharyngitis Drug Product and Services
Table 82. Pfizer Inc Pharyngitis Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Pfizer Inc Recent Developments/Updates
Table 84. Pfizer Inc Competitive Strengths & Weaknesses
Table 85. Valeant Pharmaceuticals International, Inc Basic Information, Manufacturing Base and Competitors
Table 86. Valeant Pharmaceuticals International, Inc Major Business
Table 87. Valeant Pharmaceuticals International, Inc Pharyngitis Drug Product and Services
Table 88. Valeant Pharmaceuticals International, Inc Pharyngitis Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Valeant Pharmaceuticals International, Inc Recent Developments/Updates
Table 90. Valeant Pharmaceuticals International, Inc Competitive Strengths & Weaknesses
Table 91. Mylan N.V Basic Information, Manufacturing Base and Competitors
Table 92. Mylan N.V Major Business
Table 93. Mylan N.V Pharyngitis Drug Product and Services
Table 94. Mylan N.V Pharyngitis Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Mylan N.V Recent Developments/Updates
Table 96. Mylan N.V Competitive Strengths & Weaknesses
Table 97. GSK group of companies Basic Information, Manufacturing Base and Competitors
Table 98. GSK group of companies Major Business
Table 99. GSK group of companies Pharyngitis Drug Product and Services
Table 100. GSK group of companies Pharyngitis Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. GSK group of companies Recent Developments/Updates
Table 102. GSK group of companies Competitive Strengths & Weaknesses
Table 103. Teva Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 104. Teva Pharmaceutical Industries Ltd Major Business
Table 105. Teva Pharmaceutical Industries Ltd Pharyngitis Drug Product and Services
Table 106. Teva Pharmaceutical Industries Ltd Pharyngitis Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 108. Teva Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
Table 109. AbbVie Inc Basic Information, Manufacturing Base and Competitors
Table 110. AbbVie Inc Major Business
Table 111. AbbVie Inc Pharyngitis Drug Product and Services
Table 112. AbbVie Inc Pharyngitis Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. AbbVie Inc Recent Developments/Updates
Table 114. AbbVie Inc Competitive Strengths & Weaknesses
Table 115. Viatris Inc. (Mylan) Basic Information, Manufacturing Base and Competitors
Table 116. Viatris Inc. (Mylan) Major Business
Table 117. Viatris Inc. (Mylan) Pharyngitis Drug Product and Services
Table 118. Viatris Inc. (Mylan) Pharyngitis Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. Viatris Inc. (Mylan) Recent Developments/Updates
Table 120. Viatris Inc. (Mylan) Competitive Strengths & Weaknesses
Table 121. GlaxoSmithKline plc Basic Information, Manufacturing Base and Competitors
Table 122. GlaxoSmithKline plc Major Business
Table 123. GlaxoSmithKline plc Pharyngitis Drug Product and Services
Table 124. GlaxoSmithKline plc Pharyngitis Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. GlaxoSmithKline plc Recent Developments/Updates
Table 126. GlaxoSmithKline plc Competitive Strengths & Weaknesses
Table 127. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 128. Abbott Laboratories Major Business
Table 129. Abbott Laboratories Pharyngitis Drug Product and Services
Table 130. Abbott Laboratories Pharyngitis Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 131. Abbott Laboratories Recent Developments/Updates
Table 132. Abbott Laboratories Competitive Strengths & Weaknesses
Table 133. Amgen Inc Basic Information, Manufacturing Base and Competitors
Table 134. Amgen Inc Major Business
Table 135. Amgen Inc Pharyngitis Drug Product and Services
Table 136. Amgen Inc Pharyngitis Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 137. Amgen Inc Recent Developments/Updates
Table 138. Amgen Inc Competitive Strengths & Weaknesses
Table 139. Sanofi-aventis Groupe Basic Information, Manufacturing Base and Competitors
Table 140. Sanofi-aventis Groupe Major Business
Table 141. Sanofi-aventis Groupe Pharyngitis Drug Product and Services
Table 142. Sanofi-aventis Groupe Pharyngitis Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 143. Sanofi-aventis Groupe Recent Developments/Updates
Table 144. Purdue Pharma L.P Basic Information, Manufacturing Base and Competitors
Table 145. Purdue Pharma L.P Major Business
Table 146. Purdue Pharma L.P Pharyngitis Drug Product and Services
Table 147. Purdue Pharma L.P Pharyngitis Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 148. Pharyngitis Drug Raw Material
Table 149. Key Manufacturers of Pharyngitis Drug Raw Materials
Table 150. Pharyngitis Drug Typical Distributors
Table 151. Pharyngitis Drug Typical Customers
LIST OF FIGURES
Figure 1. Pharyngitis Drug Picture
Figure 2. World Pharyngitis Drug Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Pharyngitis Drug Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Pharyngitis Drug Production (2017-2028) & (K Units)
Figure 5. World Pharyngitis Drug Average Price (2017-2028) & (US$/Unit)
Figure 6. World Pharyngitis Drug Production Value Market Share by Region (2017-2028)
Figure 7. World Pharyngitis Drug Production Market Share by Region (2017-2028)
Figure 8. North America Pharyngitis Drug Production (2017-2028) & (K Units)
Figure 9. Europe Pharyngitis Drug Production (2017-2028) & (K Units)
Figure 10. China Pharyngitis Drug Production (2017-2028) & (K Units)
Figure 11. Japan Pharyngitis Drug Production (2017-2028) & (K Units)
Figure 12. Pharyngitis Drug Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Pharyngitis Drug Demand (2017-2028) & (K Units)
Figure 15. World Pharyngitis Drug Consumption Market Share by Region (2017-2028)
Figure 16. United States Pharyngitis Drug Consumption (2017-2028) & (K Units)
Figure 17. China Pharyngitis Drug Consumption (2017-2028) & (K Units)
Figure 18. Europe Pharyngitis Drug Consumption (2017-2028) & (K Units)
Figure 19. Japan Pharyngitis Drug Consumption (2017-2028) & (K Units)
Figure 20. South Korea Pharyngitis Drug Consumption (2017-2028) & (K Units)
Figure 21. ASEAN Pharyngitis Drug Consumption (2017-2028) & (K Units)
Figure 22. India Pharyngitis Drug Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of Pharyngitis Drug by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Pharyngitis Drug Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Pharyngitis Drug Markets in 2021
Figure 26. United States VS China: Pharyngitis Drug Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Pharyngitis Drug Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Pharyngitis Drug Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Pharyngitis Drug in United States
Figure 30. Key Producers and Market Share of Pharyngitis Drug in China
Figure 31. Key Producers and Market Share of Pharyngitis Drug in Rest of World
Figure 32. World Pharyngitis Drug Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Pharyngitis Drug Production Value Market Share by Type in 2021
Figure 34. Tablet
Figure 35. Capsule
Figure 36. Spray
Figure 37. Solution
Figure 38. Other
Figure 39. World Pharyngitis Drug Production Market Share by Type (2017-2028)
Figure 40. World Pharyngitis Drug Production Value Market Share by Type (2017-2028)
Figure 41. World Pharyngitis Drug Average Price by Type (2017-2028) & (US$/Unit)
Figure 42. World Pharyngitis Drug Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 43. World Pharyngitis Drug Production Value Market Share by Application in 2021
Figure 44. Hospital Pharmacies
Figure 45. Retail Pharmacies
Figure 46. Online Pharmacies
Figure 47. World Pharyngitis Drug Production Market Share by Application (2017-2028)
Figure 48. World Pharyngitis Drug Production Value Market Share by Application (2017-2028)
Figure 49. World Pharyngitis Drug Average Price by Application (2017-2028) & (US$/Unit)
Figure 50. Manufacturing Cost Structure Analysis of Pharyngitis Drug in 2021
Figure 51. Manufacturing Process Analysis of Pharyngitis Drug
Figure 52. Pharyngitis Drug Industrial Chain
Figure 53. Distribution Channel Breakdown for Pharyngitis Drug Shipments (%): 2017-2028
Figure 54. Direct Channel Pros & Cons
Figure 55. Indirect Channel Pros & Cons
Figure 56. Methodology
Figure 57. Research Process and Data Source
Figure 1. Pharyngitis Drug Picture
Figure 2. World Pharyngitis Drug Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Pharyngitis Drug Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Pharyngitis Drug Production (2017-2028) & (K Units)
Figure 5. World Pharyngitis Drug Average Price (2017-2028) & (US$/Unit)
Figure 6. World Pharyngitis Drug Production Value Market Share by Region (2017-2028)
Figure 7. World Pharyngitis Drug Production Market Share by Region (2017-2028)
Figure 8. North America Pharyngitis Drug Production (2017-2028) & (K Units)
Figure 9. Europe Pharyngitis Drug Production (2017-2028) & (K Units)
Figure 10. China Pharyngitis Drug Production (2017-2028) & (K Units)
Figure 11. Japan Pharyngitis Drug Production (2017-2028) & (K Units)
Figure 12. Pharyngitis Drug Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Pharyngitis Drug Demand (2017-2028) & (K Units)
Figure 15. World Pharyngitis Drug Consumption Market Share by Region (2017-2028)
Figure 16. United States Pharyngitis Drug Consumption (2017-2028) & (K Units)
Figure 17. China Pharyngitis Drug Consumption (2017-2028) & (K Units)
Figure 18. Europe Pharyngitis Drug Consumption (2017-2028) & (K Units)
Figure 19. Japan Pharyngitis Drug Consumption (2017-2028) & (K Units)
Figure 20. South Korea Pharyngitis Drug Consumption (2017-2028) & (K Units)
Figure 21. ASEAN Pharyngitis Drug Consumption (2017-2028) & (K Units)
Figure 22. India Pharyngitis Drug Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of Pharyngitis Drug by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Pharyngitis Drug Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Pharyngitis Drug Markets in 2021
Figure 26. United States VS China: Pharyngitis Drug Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Pharyngitis Drug Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Pharyngitis Drug Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Pharyngitis Drug in United States
Figure 30. Key Producers and Market Share of Pharyngitis Drug in China
Figure 31. Key Producers and Market Share of Pharyngitis Drug in Rest of World
Figure 32. World Pharyngitis Drug Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Pharyngitis Drug Production Value Market Share by Type in 2021
Figure 34. Tablet
Figure 35. Capsule
Figure 36. Spray
Figure 37. Solution
Figure 38. Other
Figure 39. World Pharyngitis Drug Production Market Share by Type (2017-2028)
Figure 40. World Pharyngitis Drug Production Value Market Share by Type (2017-2028)
Figure 41. World Pharyngitis Drug Average Price by Type (2017-2028) & (US$/Unit)
Figure 42. World Pharyngitis Drug Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 43. World Pharyngitis Drug Production Value Market Share by Application in 2021
Figure 44. Hospital Pharmacies
Figure 45. Retail Pharmacies
Figure 46. Online Pharmacies
Figure 47. World Pharyngitis Drug Production Market Share by Application (2017-2028)
Figure 48. World Pharyngitis Drug Production Value Market Share by Application (2017-2028)
Figure 49. World Pharyngitis Drug Average Price by Application (2017-2028) & (US$/Unit)
Figure 50. Manufacturing Cost Structure Analysis of Pharyngitis Drug in 2021
Figure 51. Manufacturing Process Analysis of Pharyngitis Drug
Figure 52. Pharyngitis Drug Industrial Chain
Figure 53. Distribution Channel Breakdown for Pharyngitis Drug Shipments (%): 2017-2028
Figure 54. Direct Channel Pros & Cons
Figure 55. Indirect Channel Pros & Cons
Figure 56. Methodology
Figure 57. Research Process and Data Source
